Garcia-Saenz JA, Martinez-Janez N, Cubedo R, Jerez Y, et al. Sapanisertib Plus Fulvestrant in Post-Menopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer After Progression on Aromatase Inhibitor. Clin Cancer Res 2022 Jan 3. pii: 1078-0432.CCR-21-2652.
PMID: 34980598